Enanta Pharmaceuticals | ENTA - القيمة السوقية





القيمة السوقية تغيير تاريخ
AbbVie USD 435.86B 8.73B 2026-08
Amgen USD 209.65B 14.21B 2026-08
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 10.84B 664M 2026-08
AstraZeneca USD 178.16B 111.83B 2026-08
BioCryst Pharmaceuticals USD 1.9B 643M 2026-08
Biogen USD 31.9B 5B 2026-06
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Enanta Pharmaceuticals USD 122M 98M 2024-12
Gilead Sciences USD 168.68B 11.82B 2026-08
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Halozyme Therapeutics USD 10.91B 1.63B 2026-08
Heron Therapeutics USD 238M 7M 2025-12
Immunic USD 64M 23M 2025-12
Incyte USD 26.84B 4.19B 2026-08
Insmed USD 19.68B 3.43B 2026-08
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
J&J USD 611.36B 32.21B 2026-06
Karyopharm Therapeutics USD 221M 95M 2026-08
Ligand Pharmaceuticals USD 5.31B 1.02B 2026-08
Merck USD 324.18B 6.81B 2026-08
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Novartis USD 240.59B 67.17B 2026-06
Novavax USD 1.09B 316M 2025-12
Pfizer USD 153.17B 14.73B 2026-08
Roche Holding CHF 270B 3.66B 2026-06
Sarepta Therapeutics USD 1.5B 402M 2026-08
Vertex Pharmaceuticals USD 137.33B 11.26B 2026-08